Patents by Inventor Mark Cushman

Mark Cushman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250132170
    Abstract: Systems for processing articles are essential for semiconductor fabrication. These systems employ a variety of apparatuses for controlling flow. In one implementation, an apparatus for controlling flow may utilize a body having a flow path extending from an inlet to an outlet. A valve, a flow restrictor, and a pressure sensor are operably coupled to the flow path. The valve incorporates first and second actuators which enable control of mass flow rates of fluid flowing through the flow path.
    Type: Application
    Filed: October 14, 2024
    Publication date: April 24, 2025
    Applicant: Ichor Systems, Inc.
    Inventors: Philip Ryan Barros, Greg Patrick Mulligan, Christopher Bryant Davis, Randolph Treur, Gary Lei Xing, Todd Mark Cushman
  • Publication number: 20240274444
    Abstract: A method of manufacturing a substrate block for a fluid delivery system is disclosed. First, a mold is provided, the mold having a cavity. The cavity of the mold is filled with a fluoropolymer to form a substrate block having an upper surface. A curved insert is withdrawn from the cavity to form a substrate fluid passageway extending from an inlet substrate port to an outlet substrate port. The substrate fluid passageway extends between the inlet substrate port and the outlet substrate port in a smooth arc free of corners or angular walls.
    Type: Application
    Filed: April 15, 2024
    Publication date: August 15, 2024
    Inventors: Chris MELCER, Philip Ryan BARROS, Haruyuki KUBOTA, Randolph TREUR, Todd Mark CUSHMAN
  • Patent number: 12062553
    Abstract: A method of processing semiconductors using a fluid delivery system is disclosed in which seal inserts are utilized to fluidly connect an active component that bridges two substrate blocks.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: August 13, 2024
    Inventors: Chris Melcer, Phillip Ryan Barros, Haruyuki Kubota, Randolph Treur, Todd Mark Cushman
  • Patent number: 11990354
    Abstract: A substrate block for a fluid delivery system is provided, the substrate block having an upper surface. The upper surface has an inlet substrate port and an outlet substrate port formed into the upper surface. A substrate fluid passageway extends from the inlet substrate port and the outlet substrate port. The substrate fluid passageway extends in a smooth arc which is free of corners or angular walls.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: May 21, 2024
    Inventors: Chris Melcer, Phillip Ryan Barros, Haruyuki Kubota, Randolph Treur, Todd Mark Cushman
  • Publication number: 20220384217
    Abstract: A substrate block for a fluid delivery system is provided, the substrate block having an upper surface. The upper surface has an inlet substrate port and an outlet substrate port formed into the upper surface. A substrate fluid passageway extends from the inlet substrate port and the outlet substrate port. The substrate fluid passageway extends in a smooth arc which is free of corners or angular walls.
    Type: Application
    Filed: August 12, 2022
    Publication date: December 1, 2022
    Inventors: Chris MELCER, Phillip Ryan BARROS, Haruyuki KUBOTA, Randolph TREUR, Todd Mark CUSHMAN
  • Publication number: 20220028705
    Abstract: A method of processing semiconductors using a fluid delivery system is disclosed in which seal inserts are utilized to fluidly connect an active component that bridges two substrate blocks.
    Type: Application
    Filed: October 6, 2021
    Publication date: January 27, 2022
    Inventors: Chris MELCER, Phillip Ryan BARROS, Haruyuki KUBOTA, Randolph TREUR, Todd Mark CUSHMAN
  • Publication number: 20070205230
    Abstract: A fluid dispensing system includes a container, a pump assembly and a bleed valve. The pump assembly is connected to the container selectively pressurizing the container and includes an outlet port. The outlet port has a check valve precluding flow from the container through the outlet port. The bleed valve is in communication with an aperture formed through the container. The bleed valve relieves excess pressure in the container.
    Type: Application
    Filed: January 30, 2007
    Publication date: September 6, 2007
    Applicant: The Fountainhead Group, Inc.
    Inventors: Joseph Arcuri, Mark Cushman, George Mitchell, Mario Restive
  • Publication number: 20070175928
    Abstract: A fluid dispensing system includes a pump assembly for pressurizing a low cost container, the container non reversibly connected to a coupler module. A wand assembly is releasably connected to the coupler module. A discharge conduit fluidly connects the wand assembly to the container to displace a check valve in the pump assembly to permit flow from the pump assembly. The wand assembly includes a grip body slideable relative to the discharge conduit between a retracted storage position and an extended operable position.
    Type: Application
    Filed: January 30, 2006
    Publication date: August 2, 2007
    Applicant: The Fountainhead Group, Inc.
    Inventors: Joseph Arcuri, Mark Cushman, George Mitchell, Mario Restive
  • Publication number: 20060247211
    Abstract: The synthesis and biological activity of benzoisoindoloisoquinolone compounds are described. The synthesis and biological activity of C-11-substituted indenoisoquinolones are also described. Indenoisoquinolones substituted at C-11 are prepared by McMurry reactions of 11-ketoindenoisoquinolones with aldehydes.
    Type: Application
    Filed: May 11, 2004
    Publication date: November 2, 2006
    Inventors: Mark Cushman, Yves Pommier
  • Publication number: 20060025595
    Abstract: Indenoisoquinolines and dihydroindenoisoquinolines are described. In particular, such compounds possessing one or more electron withdrawing substituents are described. The in vitro anticancer activities of these molecules tested in the National Cancer Institute's screen of 55 cell lines is described. The compounds tested for topoisomerase I (top1) inhibition is described.
    Type: Application
    Filed: May 9, 2005
    Publication date: February 2, 2006
    Inventors: Mark Cushman, Andrew Morrell, Yves Pommier
  • Publication number: 20020002294
    Abstract: Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering derivatives of 2-methoxyestradiol of the general formula: 1
    Type: Application
    Filed: July 5, 2001
    Publication date: January 3, 2002
    Inventors: Robert J. D' Amato, Ravi K. Varma, Rudiger G. Haugwitz, Mark Cushman
  • Patent number: 5441941
    Abstract: Certain new 1,2-dihydroellipticine compounds having activity against CNS specific cancer cell lines because of their ease of passage across the blood-brain barrier are disclosed along with formulations and methods for treating CNS cancers employing these compounds.
    Type: Grant
    Filed: December 21, 1993
    Date of Patent: August 15, 1995
    Assignees: The United States of America as represented by the Secretary of DHHS, Purdue Research Foundation
    Inventors: Rudiger D. Haugwitz, Venkatachiala L. Narayanan, Mark Cushman, Jurjus Jurayj
  • Patent number: 5439899
    Abstract: Novel compounds having anti-HIV activity are disclosed along with formulations and methods for treating human immunodeficiency viral infections employing these compounds.
    Type: Grant
    Filed: March 10, 1993
    Date of Patent: August 8, 1995
    Assignees: Purdue Research Foundation, The United States of America as represented by the Department of Health and Human Services
    Inventors: Mark Cushman, Rudiger D. Haugwitz, Wieslaw M. Golebiewski
  • Patent number: 5272146
    Abstract: Certain new 1,2-dihydroellipticine compounds having activity against CNS specific cancer cell lines because of their ease of passage across the blood-brain barrier are disclosed along with formulations and methods for treating CNS cancers employing these compounds.
    Type: Grant
    Filed: October 2, 1992
    Date of Patent: December 21, 1993
    Assignees: The United States of America as represented by the United States Department of Health and Human Services, Purdue Research Foundation
    Inventors: Rudiger D. Haugwitz, Venkatachala L. Narayanan, Mark Cushman, Jurjus Jurayj